Delivery Order SPE2DB24D8003-SPE2DB25FJVAE
- Not listed
- The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 18 mg tablets (100-count units) valued at $3,142.26. This firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and carries no set-aside designation. The award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT...
- The Defense Logistics Agency (DLA) awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 54 mg tablets (100 count) with a ceiling value of $2,055.10. This firm fixed price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, with no set-aside designation applied. The contract represents a direct fulfillment of pharmaceutical supply requirements under Dakota Drug's...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.76 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 54 mg tablets (100 count). The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of July 28, 2025. This delivery order falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,937.66 firm fixed-price contract is for the supply of 4,564,042,715 units of the pharmaceutical product Methylphenidate ER 27 mg tablets with an ultimate completion date of March 22, 2024. No set-aside was used for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal government,...
- This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets in 100-count packages to the Defense Logistics Agency (DLA). The $3,362.34 firm fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award is not set-aside and has an ultimate completion date of May 28, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $6,484.12, is scheduled for completion by August 14, 2025, and represents performance work to be conducted at the contractor's Anoka, Minnesota location. The award utilized no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4566327375 - Methylphenidate ER 36 MG Tablets in 100 count bottles. The contract has a ceiling value of $1,664.43 and a period of performance through November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC), SPE2DB24D8001, held by Dakota Drug, Inc. under the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract valued at $7,836.12 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of 4,564,544,485 units of methylphenidate extended-release 27 mg tablets. The contract has an ultimate completion date of May 9, 2024 and is not set aside. Dakota Drug, Inc. is an experienced prime contractor to the DLA, providing a wide range of pharmaceutical products, medical...
- This is a $11,364.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of METHYLPHENIDATE ER 54 MG TAB 100S and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor that has provided a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support the medical supply chain...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,027.24 firm fixed price contract is for the delivery of 4,563,197,924 units of Methylphenidate ER 27 mg tablets in 100 count packages. This contract has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJVAEDelivery Order
The Defense Logistics Agency awarded a $4.45K firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 27 mg tablets (100-count units). The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a delivery order under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999.99M with DLA Troop Support Medical's ECAT Generation V Program. No set-aside designation was applied to this award. Dakota Drug, Inc. is a self-certified small disadvantaged business and established federal supplier specializing in pharmaceutical products and medical equipment for U.S. Armed Forces healthcare operations. The company has maintained an active presence in the federal marketplace since 2001 and holds a strategic role in the military medical supply chain through its comprehensive IDC with DLA Troop Support Medical. This delivery order for the neurological medication supports the agency's mission to provide critical pharmaceutical supplies to defense healthcare facilities across the continental United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/12/25 |